• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疑似新型冠状病毒肺炎患者的特征:大流行早期数据的回顾性分析

Profile of Patients Suspected to be COVID-19: A Retrospective Analysis of Early Pandemic Data.

作者信息

Goel Ashish, Raizada Alpana, Bansal Kamakshi, Gaur Nikhil, Abraham Jyotika, Yadav Anil

机构信息

Internal Medicine, University Respati Yogyakarta, Yogyakarta, IDN.

Internal Medicine, University College of Medical Sciences, Delhi, IND.

出版信息

Cureus. 2020 Aug 29;12(8):e10125. doi: 10.7759/cureus.10125.

DOI:10.7759/cureus.10125
PMID:33005539
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7523749/
Abstract

Background and Objectives Coronavirus disease 2019 (COVID-19), a global public health emergency of profound magnitude, has brought life to an unprecedented near-standstill. The clinical profile of the disease is still emerging and is marked by considerable geographical variability in terms of transmissibility, clinical profile, virulence, and mortality of the disease. As clinical data is being reported from around the globe, it becomes important to focus on local subjects in a global milieu, lest one misses the trees for the forest. Our study is a short retrospective analysis of the demographic and clinical profiles of subjects presenting with a mild flu-like illness to our hospital who were tested for COVID-19. It compares the differences in age and sex of those who tested positive with those negative. In addition, it reviews the length of time it might take for a case testing positive on reverse transcriptase-polymerase chain reaction (RT-PCR) test to become negative. Methodology A retrospective analysis of data from adults who presented to our hospital with a mild flu-like illness between the months of March and May 2020 was conducted to understand the disease profile. The nasal/oropharyngeal swabs were collected from each patient and were transported to state-approved laboratories chain for RT-PCR analysis. Information was collected from reports received, clinical information forms, and sample collection forms that were being maintained as a part of the clinical management protocol. Data were analysed using Stata software, version 13 (StataCorp LLC, College Station, TX, USA). Observations and Results Three thousand twenty-six subjects presented to our hospital with either mild flu-like symptoms or with suspected exposure to a confirmed case of COVID-19. The subjects had a mean age of 37.3 (± 15.1) years and 1,805 (60.3%) were males. A regression analysis revealed an adjusted odds of 1.6 (95% confidence interval (CI): 1.2, 2.1) for testing positive for males as compared to females. For every one year increase in age, the odds for testing positive increased by 1.02 (95% CI: 1.01, 1.03). Of the 2,592 individuals for whom data was available, 201 (7.6%) were found positive on RT-PCR analysis. Those testing positive were significantly older (41.0 years vs 36.8 years; p = 0.001) and more likely to be male (number: 138; 9.0% vs 6.7%; p = 0.05). Cough, followed by fever, was a common presenting feature. A survival time analysis using data from 54 participants documented 455 days of the total observation period. A median time of eight days was required for the test to convert from positive to negative if the patient remained mildly symptomatic and did not develop a severe complicated illness. The time to conversion did not differ with age or sex. Conclusions Our analysis shows that patients with COVID-19 have presented with milder symptoms and have recovered well. The low test positivity rate is indicative of the early phase of the pandemic in the country and is a reflection of active infection control measures.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58e0/7523749/5270e6de458d/cureus-0012-00000010125-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58e0/7523749/90f319ae1a94/cureus-0012-00000010125-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58e0/7523749/5270e6de458d/cureus-0012-00000010125-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58e0/7523749/90f319ae1a94/cureus-0012-00000010125-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58e0/7523749/5270e6de458d/cureus-0012-00000010125-i02.jpg
摘要

背景与目的 2019 冠状病毒病(COVID-19)是一场极为严重的全球突发公共卫生事件,已使生活几乎陷入前所未有的停滞状态。该疾病的临床特征仍在显现,其传播性、临床特征、毒力和死亡率在地理上存在显著差异。随着全球各地临床数据的报告,在全球背景下关注本地研究对象变得尤为重要,以免只见树木不见森林。我们的研究是对我院出现轻度流感样疾病并接受 COVID-19 检测的患者的人口统计学和临床特征进行的简短回顾性分析。它比较了检测呈阳性者与阴性者在年龄和性别的差异。此外,还回顾了逆转录聚合酶链反应(RT-PCR)检测呈阳性的病例转为阴性所需的时间。

方法 对 2020 年 3 月至 5 月期间我院出现轻度流感样疾病的成人数据进行回顾性分析,以了解疾病特征。从每位患者采集鼻/咽拭子,并送往国家批准的实验室进行 RT-PCR 分析。从收到的报告、临床信息表和作为临床管理方案一部分保存的样本采集表中收集信息。使用 Stata 软件 13 版(美国德克萨斯州大学站市 StataCorp 有限责任公司)进行数据分析。

观察与结果 3026 名患者因出现轻度流感样症状或疑似接触确诊 COVID-19 病例而到我院就诊。这些患者的平均年龄为 37.3(±15.1)岁,男性 1805 名(60.3%)。回归分析显示,男性检测呈阳性的校正比值比为 1.6(95%置信区间(CI):1.2,2.1),高于女性。年龄每增加一岁,检测呈阳性的几率增加 1.02(95%CI:1.01,1.03)。在可获取数据的 2592 名个体中,RT-PCR 分析发现 201 名(7.6%)呈阳性。检测呈阳性者年龄显著更大(41.0 岁对 36.8 岁;p = 0.001),且更可能为男性(人数:138 名;9.0%对 6.7%;p = 0.05)。咳嗽,其次是发热,是常见的症状表现。对 54 名参与者的数据进行生存时间分析,总观察期为 455 天。如果患者症状轻微且未发展为严重并发症,检测从阳性转为阴性的中位时间为 8 天。转阴时间在年龄和性别上无差异。

结论 我们的分析表明,COVID-19 患者症状较轻且恢复良好。低检测阳性率表明该国处于疫情早期阶段,也是积极感染控制措施的体现。

相似文献

1
Profile of Patients Suspected to be COVID-19: A Retrospective Analysis of Early Pandemic Data.疑似新型冠状病毒肺炎患者的特征:大流行早期数据的回顾性分析
Cureus. 2020 Aug 29;12(8):e10125. doi: 10.7759/cureus.10125.
2
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.用于评估非住院轻中度 COVID-19 患者肠道微生物组调节的自然史和影响的虚拟化临床研究:一项随机、开放标签、前瞻性研究,平行组研究评估 KB109 对肠道微生物组结构和功能的生理影响:一项随机对照研究方案的结构化总结。
Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0.
3
Characteristics, Treatment Outcomes and Role of Hydroxychloroquine among 522 COVID-19 hospitalized patients in Jaipur City: An Epidemio-Clinical Study.斋浦尔市522例COVID-19住院患者的羟氯喹特性、治疗结果及作用:一项流行病学临床研究
J Assoc Physicians India. 2020 Jun;68(6):13-19.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
6
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
7
Understanding the Demographic, Clinical, and Real-Time Polymerase Chain Reaction Profiles of COVID-19 Patients in a Tertiary Care Hospital in Northeast India.了解印度东北部一家三级护理医院中新冠肺炎患者的人口统计学、临床和实时聚合酶链反应特征。
Cureus. 2023 Feb 24;15(2):e35426. doi: 10.7759/cureus.35426. eCollection 2023 Feb.
8
Risk of Surgeon Contracting COVID-19 while Operating on COVID-19-Positive Patient, Impact of Safety Measures: Lessons Learnt.外科医生在为新冠病毒检测呈阳性的患者进行手术时感染新冠病毒的风险、安全措施的影响:经验教训
Surg J (N Y). 2022 Aug 22;8(3):e192-e198. doi: 10.1055/s-0042-1755619. eCollection 2022 Jul.
9
PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.PROTECT 试验:羟氯喹对比观察支持用于预防或 COVID-19 早期治疗的一项集群随机对照研究:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jul 31;21(1):689. doi: 10.1186/s13063-020-04527-4.
10
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.

引用本文的文献

1
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
2
Correlates of In-Hospital COVID-19 Deaths: A Competing Risks Survival Time Analysis of Retrospective Mortality Data.医院内 COVID-19 死亡的相关因素:回顾性死亡率数据的竞争风险生存时间分析。
Disaster Med Public Health Prep. 2022 Oct;16(5):1889-1896. doi: 10.1017/dmp.2021.85. Epub 2021 Mar 25.

本文引用的文献

1
Dynamic profile of RT-PCR findings from 301 COVID-19 patients in Wuhan, China: A descriptive study.中国武汉 301 例 COVID-19 患者的实时逆转录聚合酶链反应检测结果动态特征:一项描述性研究。
J Clin Virol. 2020 Jun;127:104346. doi: 10.1016/j.jcv.2020.104346. Epub 2020 Apr 11.
2
Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19.无症状和有症状轻症 COVID-19 患者的临床特征。
Clin Microbiol Infect. 2020 Jul;26(7):948.e1-948.e3. doi: 10.1016/j.cmi.2020.04.040. Epub 2020 May 1.
3
Clinical features of 95 sequential hospitalised patients with novel coronavirus 2019 disease (COVID-19), the first UK cohort.
95例连续性住院的2019新型冠状病毒病(COVID-19)患者的临床特征,英国首个队列研究。
J Infect. 2020 Aug;81(2):e59-e61. doi: 10.1016/j.jinf.2020.04.020. Epub 2020 Apr 27.
4
Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020.2020 年 2 月 21 日至 28 日,意大利北部帕维亚教学医院对冠状病毒病(COVID-19)的早期发现的临床特征。
Euro Surveill. 2020 Apr;25(16). doi: 10.2807/1560-7917.ES.2020.25.16.2000460.
5
Clinical Profile of Cases of COVID-19 in Far Western Province of Nepal.尼泊尔远西省新冠肺炎病例的临床概况
J Nepal Health Res Counc. 2020 Apr 20;18(1):135-137. doi: 10.33314/jnhrc.v18i1.2602.
6
Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States.美国首批 12 例 2019 年冠状病毒病(COVID-19)患者的临床和病毒学特征。
Nat Med. 2020 Jun;26(6):861-868. doi: 10.1038/s41591-020-0877-5. Epub 2020 Apr 23.
7
Clinical Characteristics of Covid-19 in New York City.纽约市新冠肺炎的临床特征
N Engl J Med. 2020 Jun 11;382(24):2372-2374. doi: 10.1056/NEJMc2010419. Epub 2020 Apr 17.
8
Clinical and epidemiologic profile of the initial COVID-19 patients at a tertiary care centre in India.印度一家三级医疗中心首批新冠肺炎患者的临床及流行病学概况
Monaldi Arch Chest Dis. 2020 Apr 10;90(1). doi: 10.4081/monaldi.2020.1294.
9
Clinical features of the first cases and a cluster of Coronavirus Disease 2019 (COVID-19) in Bolivia imported from Italy and Spain.玻利维亚首例和一组源自意大利和西班牙的 2019 冠状病毒病(COVID-19)病例的临床特征。
Travel Med Infect Dis. 2020 May-Jun;35:101653. doi: 10.1016/j.tmaid.2020.101653. Epub 2020 Apr 2.
10
Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study.85 例武汉 COVID-19 死亡病例的临床特征。一项回顾性观察研究。
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1372-1379. doi: 10.1164/rccm.202003-0543OC.